Cargando…
2197. Ceftriaxone Monotherapy vs. Ceftriaxone Plus Azithromycin for the Treatment of Community-Acquired Pneumonia in Hospitalized, Non-ICU Patients
BACKGROUND: Community-acquired pneumonia (CAP) is the leading infectious cause of death and severe sepsis in the United States and the fifth leading cause of death overall worldwide. Current United States guidelines for the treatment of CAP recommend empiric antibiotic therapy that covers both stand...
Autores principales: | Murter, Forrest, Dimond, Kristin, Gilstrap, Christopher, Grubbs, Riley, Vowell, Clark, Maldonado, Cody, Jansen, Jeffrey W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810806/ http://dx.doi.org/10.1093/ofid/ofz360.1877 |
Ejemplares similares
-
Azithromycin/ceftriaxone/hydroxychloroquine: Acute urticaria: case report
Publicado: (2020) -
Combined therapy with ceftriaxone and doxycycline does not improve the outcome of meningococcal meningitis in mice compared to ceftriaxone monotherapy
por: Ricci, Susanna, et al.
Publicado: (2020) -
Penicillin plus Ceftriaxone versus Ampicillin plus Ceftriaxone Synergistic Potential against Clinical Enterococcus faecalis Blood Isolates
por: Cusumano, Jaclyn A., et al.
Publicado: (2022) -
Levofloxacin versus ceftriaxone and azithromycin for treating community-acquired pneumonia: a randomized clinical trial study
por: Yadegarynia, Davood, et al.
Publicado: (2022) -
Azithromycin Resistance and Decreased Ceftriaxone Susceptibility in Neisseria gonorrhoeae, Hawaii, USA
por: Papp, John R., et al.
Publicado: (2017)